World's Best Scientists 2026 revealed!
Hartwig Huland

Hartwig Huland

D-Index & Metrics

Medicine

D-Index
110
Citations
45780
World Ranking
5554
National Ranking
307

Overview

Hartwig Huland is affiliated with Universität Hamburg in Germany. Their research primarily focuses on medicine, with significant contributions to biochemistry, genetics, and molecular biology. Within these broad fields, the main subfields of study for Huland include pulmonary and respiratory medicine, molecular biology, oncology, surgery, and cancer research.

The scientist has concentrated extensively on prostate cancer, covering aspects such as treatment, diagnosis, and research. Their work also touches on statistical methods in clinical trials, health systems, economic evaluations, quality of life, ubiquitin and proteasome pathways, bladder and urothelial cancer treatments, and radiopharmaceutical chemistry and applications.

Huland has published a substantial number of articles across several journals. Frequent publication venues include:

  • European Urology Open Science
  • Urologic Oncology Seminars and Original Investigations
  • Journal of Clinical Oncology
  • JAMA Network Open
  • The Prostate

Their recent papers demonstrate a focus on prostate cancer therapies and outcomes:

  • Adjuvant Versus Early Salvage Radiation Therapy for Men at High Risk for Recurrence Following Radical Prostatectomy for Prostate Cancer and the Risk of Death, 2021, Journal of Clinical Oncology
  • Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death, 2023, Journal of Clinical Oncology
  • Radical prostatectomy for localized prostate cancer: 20-year oncological outcomes from a German high-volume center, 2021, Urologic Oncology Seminars and Original Investigations
  • Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer, 2021, JAMA Network Open
  • Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features, 2021, JAMA Network Open

Collaboratively, Huland works with several frequent co-authors, including:

  • Markus Graefen
  • Derya Tilki
  • Thorsten Schlomm
  • Guido Sauter
  • Ronald Simon

Best Publications

  • Oncogenic Signaling Pathways in The Cancer Genome Atlas

    Francisco Sanchez-Vega;Marco Mina;Joshua Armenia;Walid K. Chatila

  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

    Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

  • Comprehensive Characterization of Cancer Driver Genes and Mutations.

    Matthew H Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy

    Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

  • Pathogenic Germline Variants in 10,389 Adult Cancers

    Kuan-Lin Huang;R Jay Mashl;Yige Wu;Deborah I Ritter

  • Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy.

    Alexander Haese;Alexandre de la Taille;Hendrik van Poppel;Michael Marberger

  • A PREOPERATIVE NOMOGRAM IDENTIFYING DECREASED RISK OF POSITIVE PELVIC LYMPH NODES IN PATIENTS WITH PROSTATE CANCER

    Ilias Cagiannos;Pierre Karakiewicz;James A. Eastham;Makato Ohori

  • Initial Experience of (68)Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy

    Lars Budäus;Sami-Ramzi Leyh-Bannurah;Georg Salomon;Uwe Michl

  • Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas

    Franz X. Schaub;Varsha Dhankani;Ashton C. Berger;Mihir Trivedi

  • Counseling Men With Prostate Cancer: A Nomogram for Predicting the Presence of Small, Moderately Differentiated, Confined Tumors

    Michael W. Kattan;James A. Eastham;Thomas M. Wheeler;Norio Maru

  • Integrative Genomic Analyses Reveal an Androgen-Driven Somatic Alteration Landscape in Early-Onset Prostate Cancer

    Joachim Weischenfeldt;Ronald Simon;Lars Feuerbach;Karin Schlangen

  • Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

    Joshua D. Campbell;Joshua D. Campbell;Joshua D. Campbell;Christina Yau;Christina Yau;Reanne Bowlby;Yuexin Liu

  • High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer.

    Sarah Minner;Corinna Wittmer;Markus Graefen;Georg Salomon

  • EVALUATION OF PROSTATE CANCER DETECTION WITH REAL- TIME-ELASTOGRAPHY: A COMPARISON WITH STEP SECTION PATHOLOGICAL ANALYSIS AFTER RADICAL PROSTATECTOMY

    G. Salomon;J. Köllermann;I. Thederan;T. Schlomm

  • Neurovascular Structure-adjacent Frozen-section Examination (NeuroSAFE) Increases Nerve-sparing Frequency and Reduces Positive Surgical Margins in Open and Robot-assisted Laparoscopic Radical Prostatectomy: Experience After 11 069 Consecutive Patients

    Thorsten Schlomm;Pierre Tennstedt;Caroline Huxhold;Thomas Steuber

  • Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens

    Guido Sauter;Stefan Steurer;Till Sebastian Clauditz;Till Krech

  • Urodynamic Evaluation of Changes in Urinary Control After Radical Retropubic Prostatectomy

    P. Hammerer;H. Huland

  • CHD1 Is a 5q21 Tumor Suppressor Required for ERG Rearrangement in Prostate Cancer

    Lia Burkhardt;Sarah Fuchs;Antje Krohn;Sawinee Masser

  • High Incidence of Prostate Cancer Detected by Saturation Biopsy after Previous Negative Biopsy Series

    Jochen Walz;Markus Graefen;Felix K.-H. Chun;Andreas Erbersdobler

  • Detection of Methylated Apoptosis-Associated Genes in Urine Sediments of Bladder Cancer Patients

    Martin G. Friedrich;Daniel J. Weisenberger;Jonathan C. Cheng;Shahin Chandrasoma

Frequent Co-Authors

Markus Graefen
Markus Graefen Universität Hamburg
Thorsten Schlomm
Thorsten Schlomm Charité - University Medicine Berlin
Felix K.-H. Chun
Felix K.-H. Chun Universität Hamburg
Pierre I. Karakiewicz
Pierre I. Karakiewicz University of Montreal
Ronald Simon
Ronald Simon Universität Hamburg
Francesco Montorsi
Francesco Montorsi Vita-Salute San Raffaele University
Alberto Briganti
Alberto Briganti Vita-Salute San Raffaele University
Guido Sauter
Guido Sauter Universität Hamburg
Patrizio Rigatti
Patrizio Rigatti Vita-Salute San Raffaele University
Shahrokh F. Shariat
Shahrokh F. Shariat Medical University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The healthcare field offers a variety of flexible online degree options for those looking to advance their medical careers in the USA. Many professionals are choosing online nursing and advanced practice degrees due to their convenience and accelerated timelines. If you are seeking the fastest way to obtain a Doctor of Nursing Practice (DNP) degree, you may want to explore the quickest dnp program options. These programs are designed to allow you to complete your degree in less time without sacrificing quality.

For those concerned about research requirements, some DNP programs have removed the traditional dissertation, making them more accessible. If this suits your needs, consider dnp programs without dissertation. Additionally, entry-level nurses can take advantage of fast track lpn programs online to quickly launch their careers.

For nurses aiming to specialize in mental health, there are also shortest post master's pmhnp online programs to help you transition into this high-demand field efficiently. Exploring these pathways can empower your journey in medicine through greater flexibility and diverse online options.

Best Scientists Citing Hartwig Huland

Trending Scientists

Recently Published Articles